The medicinal use of cannabis in the UK: Results of a nationwide survey

International Journal of Clinical Practice

Volumn 59, Issue 3, 2005, Pages 291-295

  Ware, Mark A ^a,c   Adams, H ^b   Guy, G W ^b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b Porton Down Science Park   (United Kingdom)

^c MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Cannabis; Chronic diseases; Epidemiology; Pain; Therapeutics

Indexed keywords

CANNABINOID; CANNABIS; RECREATIONAL DRUG;

ADULT; AGE; ALLERGY; ARTHRITIS; ARTICLE; ASTHMA; BODY WEIGHT DISORDER; BONE DISEASE; CARCINOMA; CARDIOVASCULAR DISEASE; CHRONIC FATIGUE SYNDROME; CHRONIC PAIN; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DEPRESSION; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; DYSTONIA; EPILEPSY; FEMALE; FIBROMYALGIA; GASTROINTESTINAL DISEASE; HEALTH SURVEY; HUMAN; INSOMNIA; INTERVERTEBRAL DISK DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICINAL PLANT; MENTAL DISEASE; MIGRAINE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NEUROPATHY; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY CONTROL; QUESTIONNAIRE; RECREATION; SEX DIFFERENCE; SEX RATIO; SIDE EFFECT; SKIN DISEASE; SPINAL CORD INJURY; SPINAL PAIN; SPINAL PARALYSIS; SPINE DISEASE; SPINE SURGERY; STANDARDIZATION; SURGERY; UNITED KINGDOM; UROGENITAL TRACT DISEASE; VISUAL IMPAIRMENT; WEIGHT REDUCTION;

ADULT; AGE DISTRIBUTION; AGED; CANNABIS; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; FEMALE; GREAT BRITAIN; HUMANS; MALE; MARIJUANA SMOKING; MIDDLE AGED; PHYTOTHERAPY; TREATMENT OUTCOME;

EID: 14844340153     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2004.00271.x     Document Type: Article

References (17)

1. Chatterjee A, Almahrezi A, Ware M, Fitzcharles MA. A dramatic response to inhaled cannabis in a woman with central Thalamic pain and dystonia. J Pain Symptom Manage 2002; 24 (1): 4-6.
2. Hays H. Marijuana for the management of proximal mytonic myopathy. J Pain Symptom Manage 2001; 21 (4): 267-9.
3. Holdcroft A, Smith M, Jacklin A et al. Pain relief with oral cannabinoids in familial Mediterranean fever. Anaesthesia 1997; 52 (5): 483-6.
4. Hamann W, di Vadi PP. Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors. Lancet 1999; 353: 560.
5. Ogborne AC, Smart RG, Adlaf EM. Self-reported medical use of marijuana: a survey of the general population. CMAJ 2000; 162 (12): 1685-6.
6. Ogborne AC, Smart RG, Weber T, Birchmore-Timney C. Who is using cannabis as a medicine and why: an exploratory study. J Psychoactive Drugs 2000; 32 (4): 435-43.
7. Consroe P, Musty R, Rein J, Tillery W, Pertwee R. The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 1997; 38: 44-8.
8. Ware MA, Gamsa A, Persson J, Fitzcharles MA. Cannabis for chronic pain: case series and implications for clinicians. Pain Res Manag 2002; 7 (2): 95-9.
9. Ware MA, Rueda S, Singer J, Kilby D. Cannabis use by persons living with HIV/AIDS: patterns and prevalence of use. J Cannabis Ther 2003; 3 (2): 3-15.
10. Braitstein P, Kendall T, Chan K et al. Mary-Jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents. AIDS 2001; 15 (4): 532-3.
11. Sidney S. Marijuana use in HIV-positive and AIDS patients: results of an anonymous mail survey. J Cannabis Ther 2001; 1 (3/;4): 35-41.
12. Prentiss D, Power R, Balmas G, Tzuang G, Israelski DM. Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. J Acquir Immune Defic Syndr 2004; 35 (1): 38-45.
13. Ware MA, Doyle CR, Woods R, Lynch ME, Clark AJ. Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain 2003; 102 (1-2): 211-6.
14. Page SA, Verhoef MJ, Stebbins RA, Metz LM, Levy JC. Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci 2003; 30 (3): 201-5.
15. Tseng AH, Craft RM. Sex differences in antinociceptive and motoric effects of cannabinoids. Eur J Pharmacol 2001; 430 (1): 41-7.
16. Zajicek J, Fox P, Sanders H et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 2003; 362 (9395): 1517-26.
17. Karst M, Salim K, Burstein S, Conrad I, Hoy L, Schneider U. Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial. JAMA 2003; 290 (13): 1757-62.